Attributes | Values |
---|
rdf:type
| |
Description
| - Treatment with 5-fluorouracil is known to improve survival in various cancers, mainly in colorectal cancer. Crucial metabolite of 5 FU depends on methylene-tetrahydro-folate reductase, MTHFR. We investigated 6 genetic variants in the MTHFR and MTRR genes on the clinical outcome of 273 patients treated by 5FU. One variant in MTHFR gene showed association with progression-free survival in heterozygotes and homozygotes bearers and is connected with statistically significant better survival. None of other investigated variants showed any association with the survival.
- Treatment with 5-fluorouracil is known to improve survival in various cancers, mainly in colorectal cancer. Crucial metabolite of 5 FU depends on methylene-tetrahydro-folate reductase, MTHFR. We investigated 6 genetic variants in the MTHFR and MTRR genes on the clinical outcome of 273 patients treated by 5FU. One variant in MTHFR gene showed association with progression-free survival in heterozygotes and homozygotes bearers and is connected with statistically significant better survival. None of other investigated variants showed any association with the survival. (en)
|
Title
| - 5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes
- 5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes (en)
|
skos:prefLabel
| - 5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes
- 5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes (en)
|
skos:notation
| - RIV/68378041:_____/11:00367817!RIV12-AV0-68378041
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(GAP304/10/1286), P(GP305/09/P194), V, Z(AV0Z50390512)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68378041:_____/11:00367817
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - fluorouracil; DNA-damage; nepolymorphisms (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - British Journal of Clinical Pharmacology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Försti, A.
- Hemminki, K.
- Naccarati, Alessio
- Pardini, Barbara
- Vodička, Pavel
- Kumar, R.
- Prasad, R. B.
- Bermejo, J. L.
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://bibframe.org/vocab/doi
| - 10.1111/j.1365-2125.2010.03892.x
|